The latest cancer drugs news
Browsing: Cancer Drug News
FDA approves enzalutamide for non-metastatic castration-sensitive prostate cancer with biochemical recurrence
On November 16, 2023, the US Food and Drug Administration approved enzalutamide (Xtandi, Astellas Pharma…
Breast cancer prevention drug approved for post-menopausal women in the UK – here’s how it works
Sarah Allinson, Lancaster University A drug that can halve the risk of developing breast cancer…
Drug shows promise in first-in-human trial for relapsed blood cancer
A new targeted drug, studied by researchers at The Ohio State University Comprehensive Cancer Center –…
FDA amends pembrolizumab’s gastric cancer indication
On November 7, 2023, the Food and Drug Administration revised the existing indication of pembrolizumab with…
FDA approves pembrolizumab with chemotherapy for biliary tract cancer
On October 31, 2023, the Food and Drug Administration approved pembrolizumab to be used with gemcitabine…
Predicting cancer patient response to drugs that block DNA repair
Testing for genetic biomarkers can predict which cancer patients are likely to benefit from DNA…
Metixene breakthrough: A new hope emerges for metastatic brain cancer patients
A new study has revealed that metixene, an antiparkinsonian drug, has shown remarkable potential as…
FDA approves encorafenib with binimetinib for metastatic non-small cell lung cancer with a BRAF V600E mutation
On October 11, 2023, the Food and Drug Administration approved encorafenib with binimetinib for adult patients with…
Bio-inspired drug boosts the efficacy of immunotherapy
A new, bio-inspired drug restores the effectiveness of immune cells in targeting cancer, a team…
Tumour-destroying soundwaves approved for liver cancer treatment by FDA
The United States Food and Drug Administration has approved the use of sound waves to…